Orly Pena Sanchez
General Practice · Kissimmee, FLNPI 1447212295
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AstraZeneca at 27.5% of the total. Reporting peaked in 2021 at $1,861 and has fallen 79.8% since, to $376 in 2025. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $39.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$503
- AbbVie$488
- Lilly USA, LLC$353
- GSK$296
- Johnson & Johnson$277
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,128100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $1,134 |
| Novo Nordisk | 5 | $503 |
| AbbVie | 10 | $488 |
| Lilly USA, LLC | 17 | $353 |
| GSK | 7 | $296 |
| Johnson & Johnson | 4 | $277 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $174 |
| Tactile Systems Technology Inc | 2 | $138 |
| Alkermes, Inc. | 1 | $129 |
| Exact Sciences | 6 | $126 |
| Amarin Pharma, Inc. | 4 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $79 |
| Bayer | 2 | $57 |
| Merck | 4 | $56 |
| Pfizer | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Novartis | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,128 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 11 | $2,787 |
| Atorvastatin Calcium | 32 | $460 |
| Amlodipine Besylate | 29 | $243 |
| Lisinopril | 16 | $173 |
| Metoprolol Succinate | 13 | $158 |
| Losartan Potassium | 11 | $128 |
| Metformin Hcl | 12 | $109 |
| Prednisone | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other general practice in Kissimmee
- Miguel Melendez MunozKissimmee$25K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
- Ausberto HidalgoPembroke Pines$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.